Literature DB >> 27426230

Co-morbidity in psoriasis: mechanisms and implications for treatment.

Ann Sophie Lønnberg1, Lone Skov1.   

Abstract

INTRODUCTION: Psoriasis is a common, chronic, immune-mediated inflammatory disorder. The disease is associated with several co-morbidities including cardiovascular disease, metabolic syndrome, and psychiatric disorders. It is important to identify and treat these co-morbidities because they have a strongly negative effect on the overall health of patients with psoriasis. Unfortunately, these co-morbidities are often overlooked and/or left untreated. Therefore, the aim of this review is to discuss the mechanisms of how co-morbidities are associated with psoriasis as well as implications for the clinic to be able to recognize such co-morbidities. Areas covered: This is a review of studies investigating and discussing co-morbidities of psoriasis and screening. Literature was retrieved by searching on the PubMed database using individual and combined search terms related to relevant co-morbidities. Expert commentary: Effective management of psoriasis involves targeting of both psoriasis and co-morbidities.

Entities:  

Keywords:  Psoriasis; cardiovascular disease; co-morbidities; comorbidity; genetics; inflammatory diseases; metabolic syndrome; risk factors; treatment

Mesh:

Year:  2016        PMID: 27426230     DOI: 10.1080/1744666X.2016.1213631

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  9 in total

Review 1.  The Use of Brodalumab in Three Patients with Psoriasis and Psychiatric Comorbidities.

Authors:  Ryan Rivera-Oyola; Roselyn Stanger; Graham H Litchman; Quinn Thibodeaux; John Koo; Richard Fried; Gary Goldenberg; George Han; Sylvia Hsu; Leon Kircik; Melissa Knuckles; Andrea Murina; Jeffrey Weinberg; Jashin J Wu; Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2020-12-01

2.  Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials.

Authors:  Kristian Reich; Diamant Thaçi; Georg Stingl; Jens Strodl Andersen; Line Conradsen Hiort; Michala Oron Lexner; David Winkler; Carle Paul
Journal:  Acta Derm Venereol       Date:  2022-03-28       Impact factor: 3.875

3.  Long-term safety of risankizumab from 17 clinical trials in patients with moderate-to-severe plaque psoriasis.

Authors:  K B Gordon; M Lebwohl; K A Papp; H Bachelez; J J Wu; R G Langley; A Blauvelt; B Kaplan; M Shah; Y Zhao; R Sinvhal; K Reich
Journal:  Br J Dermatol       Date:  2021-11-24       Impact factor: 11.113

4.  The Clinical Effect of Oral Vitamin D2 Supplementation on Psoriasis: A Double-Blind, Randomized, Placebo-Controlled Study.

Authors:  Wareeporn Disphanurat; Wongsiya Viarasilpa; Panlop Chakkavittumrong; Padcha Pongcharoen
Journal:  Dermatol Res Pract       Date:  2019-04-18

Review 5.  Non-Alcoholic Fatty Liver Disease (NAFLD) in Patients with Psoriasis: A Review of the Hepatic Effects of Systemic Therapies.

Authors:  Deepak M W Balak; Stefano Piaserico; Ismail Kasujee
Journal:  Psoriasis (Auckl)       Date:  2021-12-07

6.  Immunological risk factors for nonalcoholic fatty liver disease in patients with psoriatic arthritis: New predictive nomograms and natural killer cells.

Authors:  Baochen Li; Rui Su; Huanhuan Yan; Juanjuan Liu; Chong Gao; Xiaofeng Li; Caihong Wang
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

7.  Angiopoietin-like protein 2 in psoriasis: a new linkage with metabolic syndrome.

Authors:  Mohamed Zaki Kenawy; Jehan Hasan Sabry; Essam Mohamed Akl; Noha A H Emam
Journal:  Postepy Dermatol Alergol       Date:  2020-03-09       Impact factor: 1.837

8.  Psoriasis Severity-A Risk Factor of Insulin Resistance Independent of Metabolic Syndrome.

Authors:  Melita Vuksic Polic; Maja Miskulin; Martina Smolic; Kristina Kralik; Ivan Miskulin; Maja Cigrovski Berkovic; Ines Bilic Curcic
Journal:  Int J Environ Res Public Health       Date:  2018-07-13       Impact factor: 3.390

Review 9.  Is Metformin a Possible Beneficial Treatment for Psoriasis? A Scoping Review.

Authors:  Ana Maria Alexandra Stanescu; Anca Angela Simionescu; Mira Florea; Camelia Cristina Diaconu
Journal:  J Pers Med       Date:  2021-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.